UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The determinants of board structure

Journal of financial economics, 2008-02, Vol.87 (2), p.308-328

2008

Volltextzugriff (PDF)

The evolution and clinical impact of hepatitis B virus genome diversity

Nature reviews. Gastroenterology & hepatology, 2020-10, Vol.17 (10), p.618-634

2020

Volltextzugriff (PDF)

Équipe mobile de rééducation et réadaptation post-AVC : leçons à tirer d’une expérience lilloise

Annals of physical and rehabilitation medicine, 2014-05, Vol.57, p.e30-e30

2014

Volltextzugriff (PDF)

A Divergent Hepatitis D-Like Agent in Birds

Viruses, 2018-12, Vol.10 (12), p.720

2018

Volltextzugriff (PDF)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin

Frontiers in microbiology, 2021-06, Vol.12, p.652962-652962

2021

Volltextzugriff (PDF)

Signalome-wide assessment of host cell response to hepatitis C virus

Nature communications, 2017-05, Vol.8 (1), p.15158-11, Article 15158

2017

Volltextzugriff (PDF)

Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response

Nature communications, 2018-08, Vol.9 (1), p.3057-13, Article 3057

2018

Volltextzugriff (PDF)

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector

Viruses, 2023-01, Vol.15 (2), p.313

2023

Volltextzugriff (PDF)

Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models

Cell death & disease, 2021-06, Vol.12 (7), p.641-11, Article 641

2021

Volltextzugriff (PDF)

Hepatitis C Virus Nonstructural Protein 5B Is Involved in Virus Morphogenesis

Journal of Virology, 2012-05, Vol.86 (9), p.5080-5088

2012

Volltextzugriff (PDF)

Endogeneity and the dynamics of internal corporate governance

Journal of financial economics, 2012-09, Vol.105 (3), p.581-606

2012

Volltextzugriff (PDF)

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Microorganisms (Basel), 2023-08, Vol.11 (8), p.1985

2023

Volltextzugriff (PDF)

Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e66-e71

2013

Volltextzugriff (PDF)

Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells

Vaccine, 2013-04, Vol.31 (18), p.2310-2316

2013

Volltextzugriff (PDF)

A High-temperature, High-efficiency Solar Thermoelectric Generator Prototype

Energy procedia, 2014, Vol.49, p.1460-1469

2014

Volltextzugriff (PDF)

A Divergent Hepatitis D-Like Agent in Birds

Viruses, 2018-12, Vol.10 (12), p.720

2018

Volltextzugriff (PDF)

Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model

Clinical and Vaccine Immunology, 2012-02, Vol.19 (2), p.268-276

2012

Volltextzugriff (PDF)

Mapping of Spinocerebellar Ataxia 13 to Chromosome 19q13.3-q13.4 in a Family with Autosomal Dominant Cerebellar Ataxia and Mental Retardation

American journal of human genetics, 2000-07, Vol.67 (1), p.229-235

2000

Volltextzugriff (PDF)

Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein

Vaccine, 2019-03, Vol.37 (12), p.1674-1684

2019

Volltextzugriff (PDF)

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

Journal of hepatology, 2024-11, Vol.81 (5), p.794-805

2024

Volltextzugriff (PDF)

Failure of the Lamivudine-Resistant rtM204I Hepatitis B Virus Mutants To Efficiently Support Hepatitis Delta Virus Secretion

Journal of Virology, 2005-05, Vol.79 (10), p.6570-6573

2005

Volltextzugriff (PDF)

Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes

Journal of Virology, 2001-03, Vol.75 (5), p.2130-2141

2001

Volltextzugriff (PDF)

Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity

Journal of virology, 2015-11, Vol.89 (22), p.11312-11322

2015

Volltextzugriff (PDF)

Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity

Vaccine, 2020-05, Vol.38 (22), p.3892-3901

2020

Volltextzugriff (PDF)

What Do Returns to Acquiring Firms Tell Us? Evidence from Firms That Make Many Acquisitions

The Journal of finance (New York), 2002-08, Vol.57 (4), p.1763-1793

2002

Volltextzugriff (PDF)

1 – 25 von 1.749

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.042)
Mit Volltextzugriff
(953)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(692)
Science & Technology
(457)
Life Sciences & Biomedicine
(388)
Female
(370)
Male
(304)
Animals
(254)
Biological And Medical Sciences
(191)
Adult
(176)
Old Medline
(147)
Medical Sciences
(131)
Rats
(125)
Middle Aged
(124)
Pharmacology & Pharmacy
(122)
Aged
(93)
Sciences Biologiques Et Medicales
(89)
Mice
(80)
Sciences Medicales
(80)
Life Sciences
(70)
Fundamental And Applied Biological Sciences. Psychology
(67)
Rheumatology
(67)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The determinants of board structure

The evolution and clinical impact of hepatitis B virus genome diversity

Équipe mobile de rééducation et réadaptation post-AVC : leçons à tirer d’une expérience lilloise

A Divergent Hepatitis D-Like Agent in Birds

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin

Signalome-wide assessment of host cell response to hepatitis C virus

Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector

Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models

Hepatitis C Virus Nonstructural Protein 5B Is Involved in Virus Morphogenesis

Endogeneity and the dynamics of internal corporate governance

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production

Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells

A High-temperature, High-efficiency Solar Thermoelectric Generator Prototype

A Divergent Hepatitis D-Like Agent in Birds

Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model

Mapping of Spinocerebellar Ataxia 13 to Chromosome 19q13.3-q13.4 in a Family with Autosomal Dominant Cerebellar Ataxia and Mental Retardation

Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

Failure of the Lamivudine-Resistant rtM204I Hepatitis B Virus Mutants To Efficiently Support Hepatitis Delta Virus Secretion

Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes

Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity

Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity

What Do Returns to Acquiring Firms Tell Us? Evidence from Firms That Make Many Acquisitions

Suchergebnisse filtern